Taxing times are ahead for the global pharma industry in general but more particularly for Africa and the South & Southeast Asian countries.

What are the new expectations from your CEO? What will you do if you become the CEO in 2035 or 2040?

A lot has been said recently about industry changes — ones already afoot, ones being planned, and ones that need to take place. They are coming from MCI, DoP regulation, commerce, and digital technology.

You should be aware of the change-resistant culture of the pharma industry; it is slow to adopt new ways. Progress is impossible without change. As a brand manager you should stay abreast with the changing trends in order to sustain future growth and performance of brands.

What are those changes?

Shouldn’t the focus change to patient-centricity in pharma marketing? Patient-centric
approach is a natural outgrowth of H2H Mindset. Shouldn’t the focus now...